Back
Cue Biopharma Vs. Hims & Hers Health Industry Stock Comparison
Sell
40
CUE
Cue Biopharma
Last Price:
1.21
Seasonality Move:
4.73%
Buy
78
HIMS
Hims & Hers Health
Last Price:
32.27
Seasonality Move:
21.12%
Sell
40
Cue Biopharma (CUE)
is a Sell
Is Cue Biopharma a Buy, Sell or Hold?
- The current Cue Biopharma [CUE] share price is $1.22. The Score for CUE is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- CUE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
78
Hims & Hers Health (HIMS)
is a Buy
Is Hims & Hers Health a Buy, Sell or Hold?
- The current Hims & Hers Health [HIMS] share price is $32.22. The Score for HIMS is 78, which is 56% above its historic median score of 50, and infers lower risk than normal.
- HIMS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CUE Stock Price Chart
What is Cue Biopharma's stock price today?
-
The Cue Biopharma share price today is $1.22
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CUE is experiencing slight buying pressure.
HIMS Stock Price Chart
What is Hims & Hers Health's stock price today?
-
The Hims & Hers Health share price today is $32.22
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and HIMS is experiencing buying pressure, which is a positive indicator for future bullish movement.
CUE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.07 | Sell |
| Relative Strength Index (14 RSI): | 46.89 | Sell |
| Chaikin Money Flow: | 34679 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.15 - 1.71) | Sell |
| Bollinger Bands (100): | (0.58 - 1.36) | Buy |
HIMS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.43 | Buy |
| Relative Strength Index (14 RSI): | 66.63 | Buy |
| Chaikin Money Flow: | 7154065 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (20.06 - 27.92) | Buy |
| Bollinger Bands (100): | (15.64 - 23.66) | Buy |
CUE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.1 | Buy |
| 20-day SMA: | 1.38 | Sell |
| 50-day SMA: | 1.22 | Sell |
| 200-day SMA: | 1.35 | Sell |
| 8-day EMA: | 1.18 | Buy |
| 20-day EMA: | 1.28 | Sell |
| 50-day EMA: | 1.23 | Sell |
| 200-day EMA: | 1.44 | Sell |
HIMS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 27.42 | Buy |
| 20-day SMA: | 24.75 | Buy |
| 50-day SMA: | 21.64 | Buy |
| 200-day SMA: | 17.79 | Buy |
| 8-day EMA: | 28.38 | Buy |
| 20-day EMA: | 25.52 | Buy |
| 50-day EMA: | 22.55 | Buy |
| 200-day EMA: | 17.84 | Buy |
Cue Biopharma Earnings Growth & CUE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.40 per share, and an increase next year of $0.19 per share.
Hims & Hers Health Earnings Growth & HIMS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.63 per share, and an increase next year of $0.13 per share.
Cue Biopharma Technical Analysis
| Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Hims & Hers Health Technical Analysis
| Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||